Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
Acta Diabetologica
|
February 20, 2024
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study
Therese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
Plos One
|
July 21, 2015
Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
Pleun C M van Poppel, Pauline Breedveld, Evertine J Abbink, et al.
Diabetologia
|
July 22, 2022
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review
Clementine E M Verhulst, Therese W Fabricius, Steven Teerenstra, et al.
Journal of the American Heart Association
|
October 19, 2019
Sixteen-Week Physical Activity Intervention in Subjects With Increased Cardiometabolic Risk Shifts Innate Immune Function Towards a Less Proinflammatory State
Marlies P Noz, Yvonne A W Hartman, Maria T E Hopman, et al.
Diabetologia
|
February 10, 2021
Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature
Therese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2009
Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients
Tim B Koenen, Cees J Tack, Jeanne Margot Kroese, et al.
British Journal of Clinical Pharmacology
|
May 6, 2017
Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers
Elise J Smolders, Angela Colbers, Clara T M M de Kanter, et al.
The Biochemical Journal
|
August 17, 2004
Regulation of GLUT1-mediated glucose uptake by PKClambda-PKCbeta(II) interactions in 3T3-L1 adipocytes
Remko R Bosch, Merlijn Bazuine, Paul N Span, et al.
Diabetes, Obesity & Metabolism
|
July 9, 2019
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial
Cees J Tack, Stephan Jacob, Cyrus Desouza, et al.
Diabetes, Obesity & Metabolism
|
May 22, 2024
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
Cecilie H Svensson, Therese W Fabricius, Clementine E M Verhulst, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
Acta Diabetologica
|
February 20, 2024
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study
Therese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
Plos One
|
July 21, 2015
Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
Pleun C M van Poppel, Pauline Breedveld, Evertine J Abbink, et al.
Diabetologia
|
July 22, 2022
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review
Clementine E M Verhulst, Therese W Fabricius, Steven Teerenstra, et al.
Journal of the American Heart Association
|
October 19, 2019
Sixteen-Week Physical Activity Intervention in Subjects With Increased Cardiometabolic Risk Shifts Innate Immune Function Towards a Less Proinflammatory State
Marlies P Noz, Yvonne A W Hartman, Maria T E Hopman, et al.
Diabetologia
|
February 10, 2021
Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature
Therese W Fabricius, Clementine E M Verhulst, Peter L Kristensen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 13, 2009
Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients
Tim B Koenen, Cees J Tack, Jeanne Margot Kroese, et al.
British Journal of Clinical Pharmacology
|
May 6, 2017
Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers
Elise J Smolders, Angela Colbers, Clara T M M de Kanter, et al.
The Biochemical Journal
|
August 17, 2004
Regulation of GLUT1-mediated glucose uptake by PKClambda-PKCbeta(II) interactions in 3T3-L1 adipocytes
Remko R Bosch, Merlijn Bazuine, Paul N Span, et al.
Diabetes, Obesity & Metabolism
|
July 9, 2019
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial
Cees J Tack, Stephan Jacob, Cyrus Desouza, et al.
Diabetes, Obesity & Metabolism
|
May 22, 2024
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
Cecilie H Svensson, Therese W Fabricius, Clementine E M Verhulst, et al.
Page
of 19